| 注册
首页|期刊导航|中华医学杂志(英文版)|Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

Hang Zhang Chang Pan Juan Zhang Lin-Lin Zhu Kai Huang Yun Zhong Zuo-Ying Hu

中华医学杂志(英文版)2016,Vol.129Issue(18):2143-2148,6.
中华医学杂志(英文版)2016,Vol.129Issue(18):2143-2148,6.DOI:10.4103/0366-6999.189924

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

Hang Zhang 1Chang Pan 1Juan Zhang 1Lin-Lin Zhu 1Kai Huang 1Yun Zhong 1Zuo-Ying Hu1

作者信息

  • 1. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, China
  • 折叠

摘要

关键词

Angiotensin Ⅱ Receptor Antagonist/Atrial Fibrillation/Olmesartan/Pacemaker/Ventricular Pacing

Key words

Angiotensin Ⅱ Receptor Antagonist/Atrial Fibrillation/Olmesartan/Pacemaker/Ventricular Pacing

引用本文复制引用

Hang Zhang,Chang Pan,Juan Zhang,Lin-Lin Zhu,Kai Huang,Yun Zhong,Zuo-Ying Hu..Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients[J].中华医学杂志(英文版),2016,129(18):2143-2148,6.

基金项目

This work was supported by grants from Nanjing City Special Program of Medical Science (No.YKK12089) and Jiangsu Provincial Special Program of Medical Science (No.BL2013001). (No.YKK12089)

中华医学杂志(英文版)

OACSCDCSTPCD

0366-6999

访问量0
|
下载量0
段落导航相关论文